[HTML][HTML] S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil
F Lv, X Liu, B Wang, H Guo, J Li, L Shen… - International journal of …, 2014 - ncbi.nlm.nih.gov
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
[PDF][PDF] S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil
F Lv, X Liu, B Wang, H Guo, J Li, L Shen, M Jin - Int J Clin Exp Pathol, 2014 - e-century.us
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil.
F Lv, X Liu, B Wang, H Guo, J Li, L Shen… - International Journal of …, 2014 - europepmc.org
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil
F Lv, X Liu, B Wang, H Guo, J Li… - … journal of clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
[HTML][HTML] S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil
F Lv, X Liu, B Wang, H Guo, J Li, L Shen… - International Journal of …, 2014 - ncbi.nlm.nih.gov
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil
F Lv, X Liu, B Wang, H Guo, J Li… - … journal of clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil.
F Lv, X Liu, B Wang, H Guo, J Li, L Shen… - International Journal of …, 2014 - europepmc.org
The treatment choice of advanced gastric carcinoma after failure from first-line therapy is
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …
quite limited. To evaluate the efficacy and toxicity of S-1 monotherapy in patients with …